Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001641172-25-025447

Chief Executive Officer bought 25,000 shares at $2.00 ($50,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Poma Eric E Chief Executive Officer 2025-08-21 Purchase +25,000 $2.00 $50,000 25,000 D
Derivatives
Poma Eric E Chief Executive Officer 2025-08-21 Purchase · Warrant (right to buy) +25,000 25,000 D
Open-market purchases · 25,000 sh · avg $2.00 · $50,000
Loading xslF345X05/ownership.xml…